CorEvitas Inflammatory Bowel Disease (IBD) Registry

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT03162549
Status
Enrolling By Invitation

Conditions

  • Inflammatory Bowel Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Key Dates

Start date
Mar 27, 2017
Status verified
Sep 2025
Primary completion
Dec 31, 2100
Completion
Dec 31, 2100

Study Design

Enrollment
2,287 participants (estimated)

Arms

  • Arm: Inflammatory Bowel Disease
    Pts presenting to enrolling sites across the US are invited to enroll if eligible

Primary Outcome Measure

IBD epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Time Frame: A minimum of 10 years from last patient enrolled ]

Locations (1)

FacilityCityStateZIPSite coordinators
CorEvitas, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

By research site
CorEvitas, LLC· Waltham, MA

Related Studies